| Kindler HL
Systemic Treatments for Mesothelioma: Standard and Novel. [JOURNAL ARTICLE]
Curr Treat Options Oncol 2008 Sep 3.
Abstract | Full Citation |
| Rao AV, Younis IR, Sand GJ, et al.
Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia. [Journal Article]
Leuk Lymphoma 2008 Aug; 49(8):1523-9.
Abstract | Full Citation |
| Kim YJ, Bang S, Park JY, et al.
Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2008 Sep 3.
Abstract | Full Citation |
| El-Akawi ZJ, Al-Hindawi FK, Bashir NA
Alpha-1 antitrypsin (alpha1-AT) plasma levels in lung, prostate and breast cancer patients. [JOURNAL ARTICLE]
Neuro Endocrinol Lett 2008 Aug 2; 29(4)
Abstract | Full Citation |
| de Wolf C, Jansen R, Yamaguchi H, et al.
Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides. [JOURNAL ARTICLE]
Mol Cancer Ther 2008 Sep 2.
Abstract | Full Citation |
| Hou J, Wang D, Zhang R, et al.
Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action. [Journal Article]
Clin Cancer Res 2008 Sep 1; 14(17):5519-30.
Abstract | Full Citation |
| Kleespies A, Ischenko I, Eichhorn ME, et al.
Matuzumab short-term therapy in experimental pancreatic cancer: prolonged antitumor activity in combination with gemcitabine. [Journal Article]
Clin Cancer Res 2008 Sep 1; 14(17):5426-36.
Abstract | Full Citation |
| Loos M, Kleeff J, Friess H, et al.
Approaches to localized pancreatic cancer. [Journal Article]
Curr Oncol Rep 2008 May; 10(3):212-9.
Abstract | Full Citation |
| Saif MW
Does OPTIMOX Strategy ("Stop-and-Go" Approach) also Work in Treatment of Pancreatic Cancer with Oxaliplatin-Based Regimens? [Journal Article]
JOP 2008; 9(5):658-63.
Abstract | Full Citation | Find Related Articles |
| Huang CH, Millenson MM, Sherman EJ, et al.
Promising Survival in Patients with Recurrent Non-small Cell Lung Cancer Treated with Docetaxel and Gemcitabine in Combination as Second-Line Therapy. [JOURNAL ARTICLE]
J Thorac Oncol 2008 Sep; 3(9):1032-1038.
Abstract | Full Citation |
  |
New! 